21st week of 2017 patent applcation highlights part 8 |
Patent application number | Title | Published |
20170143592 | MONOMER MIXTURE FOR THE PREPARATION OF DENTAL MATERIALS | 2017-05-25 |
20170143593 | FLUOROALUMINOSILICATE GLASS POWDER | 2017-05-25 |
20170143594 | ORTHODONTIC CEMENT COMPOSITIONS AND METHODS OF USE THEREOF | 2017-05-25 |
20170143595 | Non-Spherical Droplet | 2017-05-25 |
20170143596 | CLOSED SYSTEM MOUTHPIECE WITH LIGHT AND HEAT GENERATION TO ACTIVATE A FORMULATION TO INCREASE ITS VOLUME | 2017-05-25 |
20170143597 | COMPOSITIONS FOR COSMETIC RAW MATERIAL AND METHODS FOR MAKING THE SAME | 2017-05-25 |
20170143598 | Indium Nitride Coated Particles And Compositions | 2017-05-25 |
20170143599 | Single Phase Whitening Dentifrice with High Purity Metaphosphate Abrasive | 2017-05-25 |
20170143600 | AGENTS AND METHOD FOR THE TEMPORARY SHAPING OF KERATIN-CONTAINING FIBERS | 2017-05-25 |
20170143601 | Mouthwash composition | 2017-05-25 |
20170143602 | Dual Component Oral Composition for Enhancing remineralization of teeth | 2017-05-25 |
20170143603 | PROCESS FOR SEMI-PERMANENT STRAIGHTENING OF CURLY, FRIZZY OR WAVY HAIR | 2017-05-25 |
20170143604 | Peptides and Their Use in The Treatment of Hair | 2017-05-25 |
20170143605 | Compositions Comprising Osteopontin Derivatives for the Inhibition of Hair Growth | 2017-05-25 |
20170143606 | HAIR CARE AGENTS INCLUDING CASEIN HYDROLYSATE FOR IMPROVING HAIR STRUCTURE | 2017-05-25 |
20170143607 | METHODS FOR TREATING SKIN | 2017-05-25 |
20170143608 | SKIN COLOR-IMPROVING AGENT AND COMPOSITION FOR IMPROVING SKIN COLOR | 2017-05-25 |
20170143609 | CATIONIC ARABINOXYLANS, THEIR HYDROPHOBICALLY MODIFIED PRODUCTS, AND PREPARATION METHOD AND APPLICATION THEREOF | 2017-05-25 |
20170143610 | VOLATILE OILY COMPOSITION | 2017-05-25 |
20170143611 | AGENTS AND METHOD FOR CLEANING AND/OR CARING FOR DAMAGED KERATIN FIBERS | 2017-05-25 |
20170143612 | ORAL CARE COMPOSITIONS | 2017-05-25 |
20170143613 | OIL-FREE EMOLLIENTS IN PERSONAL CARE COMPOSITIONS | 2017-05-25 |
20170143614 | HAIR TREATMENT METHOD | 2017-05-25 |
20170143615 | AGENTS AND METHOD FOR THE TEMPORARY SHAPNG OF KERATIN-CONTAINING FIBERS | 2017-05-25 |
20170143616 | ANHYDROUS COMPOSITION INCLUDING A LIPOPHILIC GELLING AGENT, AT LEAST ONE SPECIFIC FILLER AND AN OIL PHASE | 2017-05-25 |
20170143617 | WHITENING COMPOSITION COMPRISING SCUTELLARIA ALPINA EXTRACT | 2017-05-25 |
20170143618 | METHOD FOR TREATING DELETERIOUS EFFECTS ARISING FROM TATTOOS | 2017-05-25 |
20170143619 | SYSTEM, METHOD, AND KIT FOR SELECTING AND PREPARING CUSTOMIZED COSMETICS | 2017-05-25 |
20170143620 | CHEWING GUMS | 2017-05-25 |
20170143621 | PROBIOTIC TREATMENT OF SKIN DISEASES, DISORDERS, AND INFECTIONS: FORMULATIONS, METHODS AND SYSTEMS | 2017-05-25 |
20170143622 | STABLE LIQUID READY-TO-USE INJECTABLE FORMULATION OF BORTEZOMIB | 2017-05-25 |
20170143623 | ORODISPERSIBLE FILMS HAVING QUICK DISSOLUTION TIMES FOR THERAPEUTIC AND FOOD USE | 2017-05-25 |
20170143624 | Monovalent Metal Cation Dry Powders For Inhalation | 2017-05-25 |
20170143625 | NOVEL PROCESS FOR THE PREPARATION OF DRY POWDER FORMULATIONS | 2017-05-25 |
20170143626 | A PROCESS FOR THE PREPARATION of DRY POWDER FORMULATIONS | 2017-05-25 |
20170143627 | A PHARMACEUTICAL OIL-IN-WATER NANO-EMULSION | 2017-05-25 |
20170143628 | AMPHIPHILIC POLYMER | 2017-05-25 |
20170143629 | Matrix Stabilized Liposomes | 2017-05-25 |
20170143630 | COMPOSITIONS AND METHODS FOR TREATING EWING SARCOMA | 2017-05-25 |
20170143631 | LIPID FORMULATION | 2017-05-25 |
20170143632 | Process for the production of particles | 2017-05-25 |
20170143633 | NANOPARTICLES, METHOD OF PREPARING THE SAME AND THEIR USE | 2017-05-25 |
20170143634 | PHARMACEUTICAL COMPOSITION, COMPRISING PHOSPHATE BINDER PARTICLES | 2017-05-25 |
20170143635 | Methods and Compositions for Deterring Abuse | 2017-05-25 |
20170143636 | SHAPE CHANGING DRUG DELIVERY DEVICES AND METHODS | 2017-05-25 |
20170143637 | Immediate Release Abuse-Deterrent Granulated Dosage Forms | 2017-05-25 |
20170143638 | NON-DIGESTIBLE SUGAR-COATED PRODUCTS AND PROCESS | 2017-05-25 |
20170143639 | NANOCOMPOSITES OF GOLD AND POLYMERS | 2017-05-25 |
20170143640 | NANOPARTICULATE AND MACROPARTICULATE FORMULATIONS | 2017-05-25 |
20170143641 | CELL-TARGETING NANOPARTICLES COMPRISING POLYNUCLEOTIDE AGENTS AND USES THEREOF | 2017-05-25 |
20170143642 | ACTIVE PHARMACEUTICAL INGREDIENT (API) COMPRISING CANNABINOIDS FOR USE IN THE TREATMENT OF CANCER | 2017-05-25 |
20170143643 | Composition of Olivetol and Method of Use to Reduce or Inhibit the Effects of Tetrahydrocannabinol in the Human Body | 2017-05-25 |
20170143644 | Composition of Olivetol and Method of Use to Reduce or Inhibit the Effects of Tetrahydrocannabinol in the Human Body | 2017-05-25 |
20170143645 | COMPOSITIONS AND METHODS FOR DIAGNOSING OR TREATING NEUTROPHIL-MEDIATED INFLAMMATORY DISEASE | 2017-05-25 |
20170143646 | EFFECT OF LIPOPHILIC NUTRIENTS ON DIABETIC EYE DISEASES | 2017-05-25 |
20170143647 | INTESTINAL FLORA IMPROVING COMPOSITION CONTAINING ASTAXANTHIN AND ITS USE | 2017-05-25 |
20170143648 | CHARACTERIZATION OF THE COCRYSTAL PRODUCTS FORMED BY METOPROLOL AND DABIGATRAN BASES WITH L-THEANINE | 2017-05-25 |
20170143649 | IMMUNOREGULATORY AGENTS | 2017-05-25 |
20170143650 | TREATMENT OF A SKIN LESION | 2017-05-25 |
20170143651 | COMPOSITIONS OF ABSCISIC ACID FOR ANIMAL HEALTH | 2017-05-25 |
20170143652 | METHOD FOR REGULATING RETINAL ENDOTHELIAL CELL VIABILITY | 2017-05-25 |
20170143653 | USE OF SULINDAC FOR PROTECTING RETINAL PIGMENT EPITHELIAL CELLS AGAINST OXIDATIVE STRESS | 2017-05-25 |
20170143654 | GASTRIC RETENTIVE PHARMACEUTICAL COMPOSITIONS FOR TREATMENT AND PREVENTION OF CNS DISORDERS | 2017-05-25 |
20170143655 | FATTY ACID FORMULATIONS AND METHODS OF USE THEREOF | 2017-05-25 |
20170143656 | METHODS OF REDUCING THE RISK OF A CARDIOVASCULAR EVENT IN A SUBJECT ON STATIN THERAPY | 2017-05-25 |
20170143657 | COMPOSITIONS AND METHODS FOR REDUCING A FATTY ACID DESATURATION INDEX IN A SUBJECT IN NEED THEREOF | 2017-05-25 |
20170143658 | METHODS OF REDUCING THE RISK OF A CARDIOVASCULAR EVENT IN A SUBJECT ON STATIN THERAPY | 2017-05-25 |
20170143659 | METHOD FOR TREATING BLADDER CANCER | 2017-05-25 |
20170143660 | METHODS FOR TREATING INFLAMMATION AND PAIN | 2017-05-25 |
20170143661 | METHOD FOR REDUCING THE VIRAL LOAD IN POULTRY CHALLENGED WITH NEWCASTLE DISEASE (ND)/ AVIAN INFLUENZA (AI) | 2017-05-25 |
20170143662 | TIGLIEN-3-ONE DERIVATIVES | 2017-05-25 |
20170143663 | COATING COMPOSITION AND MEDICAL DEVICE | 2017-05-25 |
20170143664 | CANNABINOID FORMULATION FOR THE SEDATION AND/OR ANAESTHETIZING OF A HUMAN OR ANIMAL | 2017-05-25 |
20170143665 | SYNTHESIS AND USE OF AMINE-CONTAINING FLAVONOIDS AS POTENT ANTI-LEISHMANIAL AGENTS | 2017-05-25 |
20170143666 | COMPOSITIONS AND METHODS FOR IMPROVING MITOCHONDRIAL FUNCTION AND TREATING NEURODEGENERATIVE DISEASES AND COGNITIVE DISORDERS | 2017-05-25 |
20170143667 | Compositions and Methods for Improving Mitochondrial Function and Treating Neurodegenerative Diseases and Cognitive Disorders | 2017-05-25 |
20170143668 | USE OF NOBILETIN IN CANCER TREATMENT | 2017-05-25 |
20170143669 | LIQUID ORAL COMPOSITIONS | 2017-05-25 |
20170143670 | ORALLY DISINTEGRATING TABLET CONTAINING ASENAPINE | 2017-05-25 |
20170143671 | APREMILAST FOR THE TREATMENT OF A LIVER DISEASE OR A LIVER FUNCTION ABNORMALITY | 2017-05-25 |
20170143672 | TETRAZOLE-SUBSTITUTED ARYLAMIDES AS PX2 AND PX2/3 ANTAGONISTS | 2017-05-25 |
20170143673 | Methods For Treating Heart Failure Using Glucagon Receptor Antagonists | 2017-05-25 |
20170143674 | Use of Glutaryl Histamine for the Treatment of Respiratory Tract Diseases | 2017-05-25 |
20170143675 | FORMULATIONS FOR TREATMENT OF HYPERTHYROIDISM | 2017-05-25 |
20170143676 | Compositions and Methods for Treatment of Glaucoma | 2017-05-25 |
20170143677 | TREATMENT USING DANTROLENE | 2017-05-25 |
20170143678 | PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION | 2017-05-25 |
20170143679 | METHODS FOR IMPROVING MUSCLE AND HEART FUNCTION | 2017-05-25 |
20170143680 | MODULATORS OF PHARMACOKINETIC PROPERTIES OF THERAPEUTICS | 2017-05-25 |
20170143681 | METHODS AND COMPOSITIONS FOR TREATING PAIN | 2017-05-25 |
20170143682 | COMPOSITION COMPRISING COMBINATION OF RAPAMYCIN AND AN ACTIVATOR OF AMP KINASE AND USE THEREOF FOR TREATING DISEASES | 2017-05-25 |
20170143683 | PHARMACEUTICAL COMPOSITIONS | 2017-05-25 |
20170143684 | NOVEL FXR (NR1H4) BINDING AND ACTIVITY MODULATING COMPOUNDS | 2017-05-25 |
20170143685 | Phosphodiesesterase 4 Inhibitors for the Treatment of a Cognitive Deficit | 2017-05-25 |
20170143686 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING NEURODEGENERATIVE DISEASES | 2017-05-25 |
20170143687 | PPAR GAMMA AGONISTS FOR TREATMENT OF MULTIPLE SCLEROSIS | 2017-05-25 |
20170143688 | Multi-Tyrosine Kinase Inhibitors Derivatives and Methods of Use | 2017-05-25 |
20170143689 | C-Met Modulator Pharmaceutical Compositions | 2017-05-25 |
20170143690 | COMPOSITIONS AND METHODS FOR TREATMENT | 2017-05-25 |
20170143691 | COMPOSITIONS AND METHODS FOR TREATMENT | 2017-05-25 |